Athos Capital »

Aspire Biopharma Hldgs Inc Wt Exp 021430 shares owned by Athos Capital

Quarter-by-quarter ownership of Aspire Biopharma Hldgs Inc Wt Exp 021430 (ASBPW) shares owned by Athos Capital from 13F filings

Historical chart of Athos Capital investment in Aspire Biopharma Hldgs Inc Wt Exp 021430

Tip: Access up to 7 years of quarterly data

All positions including Aspire Biopharma Hldgs Inc Wt Exp 021430 held by Athos Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aspire Biopharma Hldgs Inc Wt Exp 021430 by Athos Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.0k 21k 0.14
2025-06-30 $6.0k 21k 0.28
2025-03-31 $12k 21k 0.56

More positions owned by Athos Capital

Kenvue (KVUE)
Hello Group Ads (MOMO)
Ke Hldgs Sponsored Ads (BEKE)
Avidity Biosciences Ord (RNA)
Hologic (HOLX)
Clearwater Analytics Hldgs I Cl A Call Option (CWAN)
Chart Industries (GTLS)
Cidara Therapeutics Com New (CDTX)
Amicus Therapeutics (FOLD)
PNM Resources (TXNM)
Liberty Broadband Corp Com Ser C (LBRDK)
Norfolk Southern (NSC)
Janus Henderson Group Ord Shs (JHG)
Joyy Ads Repstg Com A (JOYY)
Confluent Class A Com (CFLT)

View all positions for Athos Capital

Top funds holding Aspire Biopharma Hldgs Inc Wt Exp 021430

Adage Capital Partners GP
Saba Capital Management
Linden Advisors
Aristeia Capital
Highbridge Capital Management
Toronto-Dominion Bank
OZ Management
Verition Fund Management
Barclays
Millennium Management
Antara Capital
D. E. Shaw & Co
Wolverine Asset Management
Context Capital Management
Polar Securities

View all funds holding Aspire Biopharma Hldgs Inc Wt Exp 021430